Pay in 4 interest-free payments of $5.35 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
In November 2023, tirzepatide was also approved for chronic weight management in adults with obesity or overweight and at least one weight-related comorbidity
2: Reduction in Certain Diseases Recent clinical trial results suggest that the health impacts of GLP-1RAs go beyond weight loss, with the drug leading to a reduction in various diseases, such as cardiovascular disease or slowing down the progression of some illnesses such as chronic kidney disease
Annals of the New York Academy of Sciences
Potential Research Applications: Testosterone stimulation and LH activity studies Fertility and reproductive hormone models Testicular function and spermatogenesis research Endocrine system modulation investigations For laboratory research use only
Oral is most defensible when the interest is gut lining support, since that is where much of the preclinical research focused and where the oral route delivers directly
The pathogenesis of DCM is multifactorial and complex, including hyperglycemia, fatty acids, OS, inflammation, endoplasmic reticulum stress (ERS), myocardial fibrosis and hypertrophy (Parim et al., 2019)
